Dr. Kara Kelly discusses some of the most common challenges faced by adolescent and young adult patients with lymphoma.

I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, ...

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop ...

Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for ...

Panelists discuss how the EMERALD trial demonstrated elacestrant's efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its ...